These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors. Nishii R; Saga T; Sudo H; Togawa T; Kuyama J; Tani T; Maeda T; Kobayashi M; Iizasa T; Shingyoji M; Itami M; Kawamura K; Hashimoto H; Yamazaki K; Tamura K; Higashi T Ann Nucl Med; 2021 Feb; 35(2):211-222. PubMed ID: 33387282 [TBL] [Abstract][Full Text] [Related]
3. 4'-[Methyl-11C]-thiothymidine PET/CT for proliferation imaging in non-small cell lung cancer. Minamimoto R; Toyohara J; Seike A; Ito H; Endo H; Morooka M; Nakajima K; Mitsumoto T; Ito K; Okasaki M; Ishiwata K; Kubota K J Nucl Med; 2012 Feb; 53(2):199-206. PubMed ID: 22190643 [TBL] [Abstract][Full Text] [Related]
4. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake. Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019 [TBL] [Abstract][Full Text] [Related]
5. Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma. Ito K; Yokoyama J; Miyata Y; Toyohara J; Okasaki M; Minamimoto R; Morooka M; Ishiwata K; Kubota K Nucl Med Commun; 2015 Mar; 36(3):219-25. PubMed ID: 25369751 [TBL] [Abstract][Full Text] [Related]
6. Influence of volumetric 4'-[methyl- Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study. Minamimoto R; Nakaigawa N; Nagashima Y; Toyohara J; Ueno D; Namura K; Nakajima K; Yao M; Kubota K Abdom Radiol (NY); 2016 Mar; 41(3):521-30. PubMed ID: 27039323 [TBL] [Abstract][Full Text] [Related]
8. Correlation of 4'-[methyl-11C]-thiothymidine PET with Ki-67 immunohistochemistry separately in patients with newly diagnosed and recurrent gliomas. Norikane T; Mitamura K; Yamamoto Y; Hatakeyama T; Miyake K; Toyohara J; Nishiyama Y Nucl Med Commun; 2021 Dec; 42(12):1322-1327. PubMed ID: 34284440 [TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
10. Detection of colorectal cancer using ¹⁸F-FLT PET: comparison with ¹⁸F-FDG PET. Yamamoto Y; Kameyama R; Izuishi K; Takebayashi R; Hagiike M; Asakura M; Haba R; Nishiyama Y Nucl Med Commun; 2009 Nov; 30(11):841-5. PubMed ID: 19773672 [TBL] [Abstract][Full Text] [Related]
11. Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma. Okasaki M; Kubota K; Minamimoto R; Miyata Y; Morooka M; Ito K; Ishiwata K; Toyohara J; Inoue T; Hirai R; Hagiwara S; Miwa A Ann Nucl Med; 2015 Apr; 29(3):224-32. PubMed ID: 25421383 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of cell proliferation imaging with 4DST PET/CT for predicting the prognosis of patients with esophageal cancer: a comparison study with FDG PET/CT. Hotta M; Minamimoto R; Toyohara J; Nohara K; Nakajima K; Takase K; Yamada K Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2615-2623. PubMed ID: 33438100 [TBL] [Abstract][Full Text] [Related]
13. Correlation of Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455 [TBL] [Abstract][Full Text] [Related]
14. Correlation of 4'-[methyl- Takami Y; Yamamoto Y; Ueno M; Chiba Y; Norikane T; Hatakeyama T; Miyake K; Toyohara J; Nishiyama Y Ann Nucl Med; 2018 Nov; 32(9):634-641. PubMed ID: 30039191 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 4'-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging. Toyota Y; Miyake K; Kawai N; Hatakeyama T; Yamamoto Y; Toyohara J; Nishiyama Y; Tamiya T EJNMMI Res; 2015; 5():7. PubMed ID: 25853013 [TBL] [Abstract][Full Text] [Related]
17. Elevated tumor-to-liver uptake ratio (TLR) from Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134 [TBL] [Abstract][Full Text] [Related]
18. In vitro analysis of transport and metabolism of 4'-thiothymidine in human tumor cells. Plotnik DA; Wu S; Linn GR; Yip FCT; Comandante NL; Krohn KA; Toyohara J; Schwartz JL Nucl Med Biol; 2015 May; 42(5):470-474. PubMed ID: 25659855 [TBL] [Abstract][Full Text] [Related]
19. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Sampathirao N; Basu S J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019 [TBL] [Abstract][Full Text] [Related]
20. Liu S; Feng Z; Wen H; Jiang Z; Pan H; Deng Y; Zhang L; Ju X; Chen X; Wu X Jpn J Radiol; 2018 Sep; 36(9):544-550. PubMed ID: 29943313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]